Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
05/2008
05/02/2008CA2664115A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/01/2008US20080103299 Potency against gram-positive bacteria, methicillin-resistant Staphylococci aureus (MRSA), methicillin-resistant Staphylococci epidermitis (MRSE).
05/01/2008US20080103230 Monomers for polyepisulfides, polythiourethanes, or acrylic esters with internal thio groups; optical lens protective coatings with a high refractive index; reacting a bis-ethylenetrithiocarbonate sulfide or bis-ethylenetrithiocarbonate with an oxirane or thiirane and tetrafluoroboric acid catalyst
05/01/2008US20080103194 Anti-first-pass effect compounds
05/01/2008US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases
04/2008
04/30/2008EP1916250A1 Electronic devices comprising poly(dithienyl-benzodithiophenes) as semiconductors
04/30/2008CN101171257A Pyrrolobenzodiazepines compound
04/30/2008CN101168732A Method for producing Vinca rosea alkaloid
04/30/2008CN101167771A Application of vinca flower and its extraction in preparing medicine for resisting AIDS
04/30/2008CN100384857C Cephalosporin ester compound resisting beta-lactamase and its salt
04/30/2008CN100384852C Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
04/30/2008CN100384846C Fused azole-pyrimidine derivatives
04/30/2008CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/29/2008US7365205 Diamine derivatives
04/29/2008US7365066 Pyrazolopyridine derivatives as pharmaceutical agents
04/24/2008WO2008047821A1 Fused heterocyclic compound
04/24/2008WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity
04/24/2008WO2008047201A2 Solid dispersion comprising a poorly water soluble drug
04/24/2008WO2008011116A3 Aza-peptide protease inhibitors
04/24/2008US20080096867 Imidazo[1,2-A] Pyridine Anxiolytics
04/23/2008EP1912653A2 Heterocyclic benzodiazepine cgrp receptor antagonists
04/23/2008EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
04/22/2008US7361660 Chemical compounds
04/17/2008US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
04/17/2008US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
04/17/2008US20080090803 Fatty alcohol drug conjugates
04/16/2008EP1911753A1 Spiro-cyclic compound
04/16/2008CN101161656A Dibenzo tetrathiafulvalene tetracarbonyl imide derivative and preparation method and uses thereof
04/15/2008US7358326 Crosslinked polythiophene
04/15/2008US7358242 N-benzyl-2-[4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-N-isopropyl-acetamide; cholecystokinin-A (CCK-A) receptor agonist; antidiabetic; obesity
04/15/2008US7358235 Nitrobenzylthioinosine compounds for relief of pain
04/10/2008WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
04/10/2008US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example
04/09/2008EP1742953B1 Process for isolation of ergot alkaloids from ergot
04/09/2008EP1598657B1 Method for the determination of absolute configuration of chiral compounds
04/09/2008CN101157699A Method for extracting vinca alkaloids extract from Vinca rosea
04/09/2008CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure
04/09/2008CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias
04/09/2008CN100379734C Azaindoles
04/03/2008WO2008021545A3 Modulators of muscarinic receptors
04/03/2008WO2008012622A3 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
04/02/2008EP1905773A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/01/2008US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/01/2008US7351531 Molecules capable of binding to telomere and the like and method with the use of the same
03/2008
03/27/2008WO2008035629A1 Pyrazolopyrimidine derivative
03/27/2008WO2007135026A3 Substituted pteridines as therapeutic agents
03/27/2008US20080076917 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof
03/27/2008US20080076044 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
03/26/2008EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
03/26/2008CN100376572C Anti-infective agents
03/26/2008CN100376571C 6-substituted pyrido-pyrimidines
03/25/2008US7348330 1-azabicyclo [2,2,2] octan-3-one derivatives
03/25/2008CA2250002C Cephem compounds and drugs containing the compounds
03/20/2008US20080070932 unexpectedly potent antagonists of A2a adenosine receptor; Parkinson's; neurodegenerative diseases; 2-furan-2-yl-N5-[1-(5-methyl-isoxazol-3-ylmethyl)-pyrrolidin-2-ylmethyl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine
03/20/2008US20080070906 Quinolinone derivatives
03/19/2008EP1900738A2 Substituted pyrroline kinase inhibitors
03/19/2008EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects
03/18/2008US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
03/13/2008WO2008008480A3 Nitroheteroaryl-containing rifamycin derivatives
03/13/2008WO2007127635A3 Diketo-piperazine and piperidine derivatives as antiviral agents
03/12/2008EP1896474A1 Detectable threading intercalator
03/12/2008EP1896472A1 Alpha-carbolines as cdk-1 inhibitors
03/12/2008EP1641799B1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
03/12/2008EP1404675B1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
03/12/2008CN100374446C Method for separating vindoline , catharanthine, vinblastine and vincristine from Vinca rosea
03/12/2008CN100374445C Method for purifying Vinorelbine Bitartrate
03/11/2008US7342011 Rifamycin analogs and uses thereof
03/11/2008US7342006 Substituted 8-heteroaryl xanthines
03/05/2008EP1893599A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/05/2008CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease
03/05/2008CN100372848C Spiroazacyclic compounds as monoamine receptor modulators
02/2008
02/28/2008WO2008009700A8 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
02/28/2008WO2008003766A3 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
02/28/2008US20080051425 Vinorelbine derivatives
02/28/2008US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
02/27/2008EP1891078A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
02/27/2008EP1891077A1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
02/27/2008EP1891050A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
02/27/2008EP1562955B1 Quinazoline derivatives as src tyrosine kinase inhibitors
02/27/2008EP1558616B1 Meso-substituted porphyrins
02/27/2008EP1506192B1 Substituted pyrroline kinase inhibitors
02/27/2008EP1483266B1 Spiro compounds with npy antagonistic activity
02/27/2008EP1039906B1 metal complexes with antibacterian and fungicidal effects
02/26/2008US7335774 Quinolinone derivatives
02/26/2008US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties
02/21/2008WO2008021545A2 Modulators of muscarinic receptors
02/21/2008WO2008020902A1 Substituted spirocyclic cgrp receptor antagonists
02/21/2008WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND
02/21/2008WO2008020611A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
02/21/2008WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
02/21/2008WO2007130860A3 Constrained compounds as cgrp-receptor antagonists
02/21/2008US20080045563 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
02/21/2008US20080045527 Immunomodulating Heterocyclic Compounds
02/21/2008US20080045524 Selective NPY (Y5) antagonists
02/21/2008US20080044923 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na
02/21/2008CA2660974A1 Modulators of muscarinic receptors
02/21/2008CA2650932A1 Substituted spirocyclic cgrp receptor antagonists
02/20/2008EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
02/20/2008EP1889624A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
02/20/2008EP1888587A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 111